Azithromycin, a questionable treatment for COVID-19

Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID‐19 by dual binding to IL-6/STAT3

“…Most COVID-19 patients are moderate [ [2] , [3] , [4] , [5] ]. Although some drugs and vaccinations have been recommended for use, new effective strategies are still being developed due to side effects, toxicity and allergic reactions [ [6] , [7] , [8] , [9] , [10] ].…”